Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives

The selection of treatment according to genomic alterations is a standard approach in metastatic colorectal cancer but is only starting to have an impact in the earlier stages of the disease. The status if genes like KRAS, BRAF, and MMR has substantial survival implications, and concerted research e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherji, Reetu, Marshall, John L., Seeber, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465976/
https://www.ncbi.nlm.nih.gov/pubmed/32707813
http://dx.doi.org/10.3390/cancers12082001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465976/
https://www.ncbi.nlm.nih.gov/pubmed/32707813
http://dx.doi.org/10.3390/cancers12082001

Ejemplares similares